Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 23

1.
2.

Cerebrovascular risk factors in Alzheimer's disease: brain hemodynamics and pharmacogenomic implications.

Cacabelos R, Fernández-Novoa L, Lombardi V, Corzo L, Pichel V, Kubota Y.

Neurol Res. 2003 Sep;25(6):567-80. Review.

PMID:
14503010
3.

Hypertension, hypertension-clustering factors and Alzheimer's disease.

Skoog I, Gustafson D.

Neurol Res. 2003 Sep;25(6):675-80. Review.

PMID:
14503023
4.

Shared genetic etiology underlying Alzheimer's disease and type 2 diabetes.

Hao K, Di Narzo AF, Ho L, Luo W, Li S, Chen R, Li T, Dubner L, Pasinetti GM.

Mol Aspects Med. 2015 Jun-Oct;43-44:66-76. doi: 10.1016/j.mam.2015.06.006. Epub 2015 Jun 23. Review.

PMID:
26116273
5.

Alzheimer disease and cerebrovascular pathology: an update.

Jellinger KA.

J Neural Transm (Vienna). 2002 May;109(5-6):813-36. Review.

PMID:
12111471
6.

Diagnosis and management of vascular cognitive impairment and dementia.

Erkinjuntti T.

J Neural Transm Suppl. 2002;(63):91-109. Review.

PMID:
12597611
7.

Dietary fats, cerebrovasculature integrity and Alzheimer's disease risk.

Takechi R, Galloway S, Pallebage-Gamarallage MM, Lam V, Mamo JC.

Prog Lipid Res. 2010 Apr;49(2):159-70. doi: 10.1016/j.plipres.2009.10.004. Epub 2009 Nov 5. Review.

PMID:
19896503
8.

The early contribution of cerebrovascular factors to the pathogenesis of Alzheimer's disease.

Pimentel-Coelho PM, Rivest S.

Eur J Neurosci. 2012 Jun;35(12):1917-37. doi: 10.1111/j.1460-9568.2012.08126.x. Review.

PMID:
22708603
9.
10.

Plasma and cerebrospinal fluid amyloid beta for the diagnosis of Alzheimer's disease dementia and other dementias in people with mild cognitive impairment (MCI).

Ritchie C, Smailagic N, Noel-Storr AH, Takwoingi Y, Flicker L, Mason SE, McShane R.

Cochrane Database Syst Rev. 2014 Jun 10;(6):CD008782. doi: 10.1002/14651858.CD008782.pub4. Review.

PMID:
24913723
11.

From genetics to dietetics: the contribution of epidemiology to understanding Alzheimer's disease.

Barberger-Gateau P, Lambert JC, Féart C, Pérès K, Ritchie K, Dartigues JF, Alpérovitch A.

J Alzheimers Dis. 2013;33 Suppl 1:S457-63. doi: 10.3233/JAD-2012-129019. Review.

PMID:
22683527
12.

Alzheimer's disease genetics current status and future perspectives.

Bertram L.

Int Rev Neurobiol. 2009;84:167-84. doi: 10.1016/S0074-7742(09)00409-7. Review.

PMID:
19501718
13.

Vascular aspects in Alzheimer's disease.

Skoog I.

J Neural Transm Suppl. 2000;59:37-43. Review.

PMID:
10961416
14.

Alzheimer's disease is a vasocognopathy: a new term to describe its nature.

de la Torre JC.

Neurol Res. 2004 Jul;26(5):517-24. Review.

PMID:
15265269
15.

White matter hyperintensities as early and independent predictors of Alzheimer's disease risk.

Mortamais M, Artero S, Ritchie K.

J Alzheimers Dis. 2014;42 Suppl 4:S393-400. doi: 10.3233/JAD-141473. Review.

PMID:
25261452
16.

Epidemiology and etiology of Alzheimer's disease: from genetic to non-genetic factors.

Jiang T, Yu JT, Tian Y, Tan L.

Curr Alzheimer Res. 2013 Oct;10(8):852-67. Review.

PMID:
23919770
17.

Fibrinogen, a possible key player in Alzheimer's disease.

Cortes-Canteli M, Strickland S.

J Thromb Haemost. 2009 Jul;7 Suppl 1:146-50. doi: 10.1111/j.1538-7836.2009.03376.x. Review.

18.

Omega-3 fatty acids for the treatment of dementia.

Burckhardt M, Herke M, Wustmann T, Watzke S, Langer G, Fink A.

Cochrane Database Syst Rev. 2016 Apr 11;4:CD009002. doi: 10.1002/14651858.CD009002.pub3. Review.

PMID:
27063583
19.

[Blood pressure and Alzheimer's disease].

Pasquier F, Leys D.

Rev Neurol (Paris). 1998 Nov;154(11):743-51. Review. French.

PMID:
9894287
20.

Age-related inflammatory diseases: role of genetics and gender in the pathophysiology of Alzheimer's disease.

Candore G, Balistreri CR, Grimaldi MP, Vasto S, Listì F, Chiappelli M, Licastro F, Lio D, Caruso C.

Ann N Y Acad Sci. 2006 Nov;1089:472-86. Review.

PMID:
17261790

Supplemental Content

Support Center